Lilly Asia Ventures For Profit
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Invests into
%20.jpg)
.png)
%20.jpg)
Industry:
Longevity Biomarkers
Estimated Revenue:
$6.4 Million
Number Of Exists:
39
Headquarters:
Shanghai, Shanghai, China
Investor Type:
Venture Debt
Employee Number:
11-50
Investment Stage:
Early Stage Venture, Late Stage Venture
Founded Date:
2008-01-01